🇺🇸 naratriptan HCl in United States

51 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 8 reports (15.69%)
  2. Headache — 7 reports (13.73%)
  3. Condition Aggravated — 5 reports (9.8%)
  4. Drug Ineffective — 5 reports (9.8%)
  5. Malaise — 5 reports (9.8%)
  6. Migraine — 5 reports (9.8%)
  7. Feeling Abnormal — 4 reports (7.84%)
  8. Hot Flush — 4 reports (7.84%)
  9. Hyperhidrosis — 4 reports (7.84%)
  10. Sleep Apnoea Syndrome — 4 reports (7.84%)

Source database →

Other Neurology approved in United States

Frequently asked questions

Is naratriptan HCl approved in United States?

naratriptan HCl does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for naratriptan HCl in United States?

Cady, Roger, M.D. is the originator. The local marketing authorisation holder may differ — check the official source linked above.